先进的神经成像和质母细胞瘤新兴系统疗法:当前证据和未来方向
Ilona Bar-Letkiewicz1,2, Anna Pieczyńska1,3, Małgorzata Dudzic4
1Greater Poland Cancer Centre, 15 Garbary St., 61-866 Poznan, Poland.
Biomedicines
|November 27, 2025
概括
质母细胞瘤 (GBM) 治疗的进步结合了神经成像,人工智能和新疗法. 虽然标准护理仍然存在,但新兴的策略旨在通过整合诊断和向治疗来改善患者的治疗结果,以提高生存率.
科学领域:
- 神经瘤学神经瘤学
- 医学成像医学成像
- 癌症治疗方法 癌症治疗方法
背景情况:
- 质母细胞瘤 (GBM) 仍然是一个具有挑战性的脑瘤,尽管技术进步,预后不佳.
- 神经成像在诊断和监测包括GBM在内的脑瘤中起着至关重要的作用.
研究的目的:
- 审查目前的神经成像技术和针对GBM的全身疗法.
- 突出质母细胞瘤的新兴和创新的治疗策略.
主要方法:
- 综述多参数MRI (扩散, perfusion,光谱),PET标记剂,放射学和AI.
- 对标准治疗方法 (手术,用temozolomide进行化学放射治疗) 和新疗法 (贝瓦西祖马布,免疫检查点抑制剂,CAR-T细胞,向治疗) 的分析.
主要成果:
- 使用人工智能的高级成像 (MRI,PET) 完善了瘤划分和反应预测.
- 标准疗法 (temozolomide) 在MGMT甲基化GBM中最有效;其他向疗法显示出有限的整体生存益处.
- 像CAR-T和向药物等新兴疗法显示初步活性,但缺乏在未经选择的GBM中经过证明的耐用性或广泛有效性.
结论:
- 集成先进的成像,人工智能和分子数据对于改善GBM预后和治疗选择至关重要.
- 未来的研究应该专注于血脑屏障透策略和协调的诊断治疗方法.
- 这些领域的融合有望改善质母细胞瘤患者的治疗结果.
关键词:
在CAR-T细胞中.通过MGMT促进剂甲基化.在PET中使用PET标记剂.人工智能的人工智能是人工智能.质母细胞瘤是什么多参数核磁共振成像 (MRI)无线电学 (radiomics) 是一种无线电学.有针对性的治疗.泰莫索洛米德 (temozolomide) 是一种有毒的物质.更多相关视频
09:18Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
Published on: July 16, 2018
8.7K
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
2.9K
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).